bpc 157 and tb 500 canada BPC-157 + TB-500 | The Peptide Labs BPC-157 + TB-500 Capsules |

Patients who should not receive BPC-157 include: those with active or recent malignancies (due to angiogenic concerns), pregnant or breastfeeding women (no reproductive toxicology data in humans), patients on anticoagulation therapy (theoretical bleeding risk from angiogenesis at ulcer sites), and minors (no pediatric data of any kind)

The same applies if you develop severe dizziness, breathing difficulties, irregular heartbeat, or chest pain after your injection

Barrier currently offers one main BPC-GI tablet

Which one is relevant depends on the pathway a given research question targets

Here are my thoughts on the recent surge in 'injury healing' peptides

Fatigue, brain fog, and low mood